查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2022-2028 年耐甲氧西林金黃色葡萄球菌 (MRSA) 抗生素市場
市場調查報告書
商品編碼
1215733

2022-2028 年耐甲氧西林金黃色葡萄球菌 (MRSA) 抗生素市場

Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotic Market 2022-2028
出版日期: | 出版商: Orion Market Research | 英文 | 商品交期: 2-3個工作天內

價格

全球 MRSA 抗生素市場預計在預測期內將以 5.5% 的複合年增長率顯著增長，這要歸功於研發活動的增加以及針對 MRSA 相關感染治療的各種研究。 例如，2019 年 9 月，杜克大學健康中心的研究人員領導的一項研究表明，遺傳易感性似乎使一個人更有可能成功抵抗抗生素耐藥性葡萄球菌感染。 這一發現增加了對使某些人易患持續性耐甲氧西林金黃色葡萄球菌 (MRSA) 感染的遺傳因素的重要認識，並可能導致開發更好的治療方法。 該研究還提供了基因突變的有力證據，這些基因突變可能有助於 MRSA 感染者解決血液感染問題。 此外，廠商對達托黴素、萬古黴素等先進藥物的開發重點也在推動MRSA治療市場的增長。

全球 MRSA 抗生素市場根據治療類型、分銷渠道進行細分。 根據治療類型，市場分為萬古黴素、四環素、利奈唑胺、達托黴素和脂□。 基於分銷渠道，市場細分為在線醫院藥房和零售藥房。 在上述細分市場中，四環素是另一種也影響欠市場的藥物，因為它通過與細菌 30S 核醣體可逆結合來阻止細菌蛋白質合成。 四環素類抗生素對革蘭氏陽性和革蘭氏陰性細菌有效。

市場按地域劃分如下： 北美、歐洲、亞太地區和世界其他地區。 預計亞太地區將在預測期內以最快的速度增長。 這是因為中國和印度龐大的患者群體以及印度對抗生素的無節制消費，估計將推動亞太地區 MRSA 抗生素市場的增長。

內容

第 1 章報告概述

  • 當前行業分析和增長前景
  • COVID-19 對全球 MRSA 抗生素市場的影響
  • 全球 MRSA 抗生素市場復甦情景
  • 研究方法和工具
  • 市場細分
    • 按細分
    • 按地區

第 2 章市場概述和洞察

  • 調查範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 推薦
    • 總結

第三章競爭格局

  • 默克集團。
    • 概覽
    • 財務分析
    • SWOT 分析
    • 近期趨勢
  • Olon 活性藥物
    • 概覽
    • 財務分析
    • SWOT 分析
    • 近期趨勢
  • 輝瑞公司
    • 概覽
    • 財務分析
    • SWOT 分析
    • 近期趨勢
  • Viatris 公司
    • 概覽
    • 財務分析
    • SWOT 分析
    • 近期趨勢
  • 禮來公司
    • 概覽
    • 財務分析
    • SWOT 分析
    • 近期趨勢
  • 關鍵策略分析
  • COVID-19 對主要參與者的影響

第四章市場細分

  • 按治療類型劃分的 MRSA 抗生素全球市場
    • 萬古黴素
    • 四環素
    • 利奈唑胺
    • 達托黴素
    • 脂□
  • MRSA 抗生素的全球市場：按分銷渠道分類
    • 在線
    • 醫院藥房
    • 零售店

第五章區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 意大利
    • 西班牙
    • 法國
    • 其他歐洲
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 世界其他地方

第六章公司簡介

  • Allergan Inc.
  • Baxter International Inc.
  • Cumberland Pharmaceuticals Inc.
  • Debiopharm International
  • Fresenius Kabi AG
  • Innovation Pharmaceuticals Inc.
  • Melinta therapeutics Inc.
  • Nabriva Therapeutics Plc.
  • North China Pharmaceutical Group Corp.
  • Novartis International AG
  • Paratek Pharmaceuticals Inc.
  • Sanofi-Aventis Groupe
  • Teva Pharmaceutical Industries Ltd.
  • Theravance Biopharma Inc.
  • Xellia Pharmaceuticals ApS
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Zhejiang Medicine Co., Ltd.
Product Code: OMR2026789

Title:Global Methicillin-Resistant Staphylococcus Aureus (MRSA) antibiotic Market Size, Share & Trends Analysis Report by Treatment Type (Vancomycin, Tetracycline, Linezolid, Daptomycin, and Lipopeptide), and by Distribution Channel (Online, Hospital Pharmacies and Retail Pharmacies) Forecast 2022-2028.

The global MRSA antibiotic market is anticipated to grow at a substantial CAGR of 5.5% during the forecast period, owing to increasing research and development activities and various studies for the treatment of infections associated with MRSA. For instance, in September 2019, a study led by Duke Health researchers showed that an inherited genetic tendency appears to increase the likelihood that a person can successfully fight off antibiotic-resistant staph infections. The finding adds important insights into the genetic factors that predispose some people to persistent methicillin-resistant Staphylococcus aureus (MRSA) infections and could lead to the development of better treatment options. The study also provides strong evidence of a genetic variant that appears to support people with MRSA to resolve their bloodstream infections. Moreover, the increasing focus of manufacturers on the development of advanced drugs such as Daptomycin, and Vancomycin, among others, are also supporting the market growth for the treatment of MRSA.

The global MRSA antibiotic market is segmented based on the treatment type, and distribution channel. Based on the treatment type, the market is segmented into vancomycin, tetracycline, linezolid, daptomycin, and lipopeptide. Based on distribution channel the market is sub segmented into online hospital pharmacies and retail pharmacies. Among the above segment, tetracyclines is another drug that also impacts the market owing it prevents bacterial protein synthesis by reversibly binding to the bacterial 30S ribosomes. They act against gram-positive and gram-negative bacteria.

Geographically market is segmented into: North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific is set to grow at the fastest rate during the forecast period, owing to the huge patient pool in China and India and the uncontrolled consumption of antibiotics in India is estimated to fuel the growth of the MRSA antibiotic market in Asia Pacific.

The major companies serving the global MRSA antibiotic market include Merck Group., Olon Active Pharmaceutical, Pfizer Inc., Viatris Inc., Eli Lilly and Company, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers & acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in July 2021, Melinta Therapeutics announced the commercial launch of KIMYRSA, a lipoglycopeptide antibiotic that delivers a complete course of therapy for acute bacterial skin and skin structure infections. The US food and drug administration approved KIMYRSA on March 12, 2021, for the treatment of adult patients.

Research Methodology

The market study of the global MRSA antibiotic market is incorporated by extensive primary and secondary research conducted by the research team at OMR. Secondary research has been conducted to refine the available data to breakdown the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings authenticity to our reports.

Secondary Sources Include:

  • Financial reports of companies involved in the market.
  • Whitepapers, research papers, and news blogs.
  • Company websites and their product catalog.

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

  • Global MRSA antibiotic Market Research and Analysis by Treatment Type
  • Global MRSA antibiotic Market Research and Analysis by Distribution Channel

The Report Covers:

  • Comprehensive research methodology of the global MRSA antibiotic market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the global MRSA antibiotic market.
  • Insights about market determinants that are stimulating the global MRSA antibiotic market.
  • Detailed and extensive market segments with the regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • Impact of COVID-19 on The Global MRSA Antibiotic Market
  • Recovery Scenario of Global MRSA Antibiotic Market
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. BY Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Merck Group.
    • 3.1.1. Overview
    • 3.1.2. Financial Analysis
    • 3.1.3. SWOT Analysis
    • 3.1.4. Recent Developments
  • 3.2. Olon Active Pharmaceutical
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Pfizer Inc.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Viatris Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Eli Lilly and Co.
    • 3.5.1. Overview
    • 3.5.2. Financial Analysis
    • 3.5.3. SWOT Analysis
    • 3.5.4. Recent Developments
  • 3.6. Key Strategy Analysis
  • 3.7. Impact of Covid-19 on Key Players

4. Market Segmentation

  • 4.1. Global MRSA Antibiotic Market by Treatment Type
    • 4.1.1. Vancomycin
    • 4.1.2. Tetracycline
    • 4.1.3. Linezolid
    • 4.1.4. Daptomycin
    • 4.1.5. Lipopeptide
  • 4.2. Global MRSA Antibiotic Market by Distribution Channel
    • 4.2.1. Online
    • 4.2.2. Hospital Pharmacies
    • 4.2.3. Retail Pharmacies

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Allergan Inc.
  • 6.2. Baxter International Inc.
  • 6.3. Cumberland Pharmaceuticals Inc.
  • 6.4. Debiopharm International
  • 6.5. Fresenius Kabi AG
  • 6.6. Innovation Pharmaceuticals Inc.
  • 6.7. Melinta therapeutics Inc.
  • 6.8. Nabriva Therapeutics Plc.
  • 6.9. North China Pharmaceutical Group Corp.
  • 6.10. Novartis International AG
  • 6.11. Paratek Pharmaceuticals Inc.
  • 6.12. Sanofi-Aventis Groupe
  • 6.13. Teva Pharmaceutical Industries Ltd.
  • 6.14. Theravance Biopharma Inc.
  • 6.15. Xellia Pharmaceuticals ApS
  • 6.16. Zhejiang Hisun Pharmaceutical Co., Ltd.
  • 6.17. Zhejiang Medicine Co., Ltd.

LIST OF TABLES

  • 1. GLOBAL MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2021-2028 ($ MILLION)
  • 2. GLOBAL VANCOMYCIN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 3. GLOBAL TETRACYCLINES MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 4. GLOBAL LINEZOLID MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 5. GLOBAL DAPTOMYCIN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 6. GLOBAL LIPOPEPTIDE MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 7. GLOBAL MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 8. GLOBAL MRSA ANTIBIOTIC BY ONLINE DISTRIBUTION CHANNEL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 9. GLOBAL MRSA ANTIBIOTIC BY HOSPITAL PHARMACIES DISTRIBUTION CHANNEL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 10. GLOBAL MRSA ANTIBIOTIC BY RETAIL PHARMACIES DISTRIBUTION CHANNEL MARKET RESEARCH AND ANALYSIS BY REGION, 2021-2028 ($ MILLION)
  • 11. GLOBAL MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2021-2028 ($ MILLION)
  • 12. NORTH AMERICAN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 13. NORTH AMERICAN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2021-2028 ($ MILLION)
  • 14. NORTH AMERICAN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 15. EUROPEAN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 16. EUROPEAN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2021-2028 ($ MILLION)
  • 17. EUROPEAN MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 18. ASIA-PACIFIC MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 19. ASIA-PACIFIC MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2021-2028 ($ MILLION)
  • 20. ASIA-PACIFIC MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)
  • 21. REST OF THE WORLD MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2021-2028 ($ MILLION)
  • 22. REST OF THE WORLD MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY TREATMENT TYPE, 2021-2028 ($ MILLION)
  • 23. REST OF THE WORLD MRSA ANTIBIOTIC MARKET RESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2021-2028 ($ MILLION)

LIST OF FIGURES

  • 1. IMPACT OF COVID-19 ON GLOBAL MRSA ANTIBIOTIC MARKET, 2021-2028 ($ MILLION)
  • 2. IMPACT OF COVID-19 ON GLOBAL MRSA ANTIBIOTIC MARKET BY SEGMENT, 2021-2028 ($ MILLION)
  • 3. RECOVERY OF GLOBAL MRSA ANTIBIOTIC MARKET, 2022-2028 (%)
  • 4. GLOBAL MRSA ANTIBIOTIC MARKET BY TREATMENT TYPE, 2021 VS 2028 (%)
  • 5. GLOBAL VANCOMYCIN MRSA ANTIBIOTIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 6. GLOBAL TETRACYCLINE MRSA ANTIBIOTIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 7. GLOBAL LINEZOLID MRSA ANTIBIOTIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 8. GLOBAL DAPTOMYCIN MRSA ANTIBIOTIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 9. GLOBAL LIPOPEPTIDE MRSA ANTIBIOTIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 10. GLOBAL MRSA ANTIBIOTIC MARKET SHARE BY DISTRIBUTION CHANNEL, 2021 VS 2028 (%)
  • 11. GLOBAL MRSA ANTIBIOTIC BY ONLINE DISTRIBUTION CHANNEL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 12. GLOBAL MRSA ANTIBIOTIC BY HOSPITAL PHARMACIES DISTRIBUTION CHANNEL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 13. GLOBAL MRSA ANTIBIOTIC BY RETAIL PHARMACIES DISTRIBUTION CHANNEL MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 14. GLOBAL MRSA ANTIBIOTIC MARKET SHARE BY GEOGRAPHY, 2021 VS 2028 (%)
  • 15. US MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
  • 16. CANADA MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
  • 17. UK MRSA ANTIBIOTICMARKET SIZE, 2021-2028 ($ MILLION)
  • 18. FRANCE MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
  • 19. GERMANY MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
  • 20. ITALY MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
  • 21. SPAIN MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
  • 22. REST OF EUROPE MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
  • 23. INDIA MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
  • 24. CHINA MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
  • 25. JAPAN MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
  • 26. SOUTH KOREA MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
  • 27. REST OF ASIA-PACIFIC MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)
  • 28. REST OF THE WORLD MRSA ANTIBIOTIC MARKET SIZE, 2021-2028 ($ MILLION)